News
Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...
11h
Futurism on MSNHuman Experiments on GLP-1 Pill Looking Extremely PromisingA new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.
Semaglutide promising alternative treatment for chronic myopathy of hyperkalemic periodic paralysis suggests a case report ...
A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...
11d
Verywell Health on MSNFoods to Eat and Avoid While on Semaglutide for Optimal ResultsSemaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
An Ashland physician and owner of Lewis Family Care, Matthew Lewis, 44, has pleaded guilty at U.S. District Court in Ashland ...
With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...
For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.
7h
Lose It! on MSNCoping With Common Side Effects of GLP-1 MedicationsIf you are taking a weight loss medication such as Ozempic, Wegovy, or Zepbound for obesity or other health concerns, you may ...
HealthDay News — The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research ...
Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results